Cloetta AB (publ) Earnings Calls
| Release date | Nov 05, 2025 |
| EPS estimate | kr0.610 |
| EPS actual | kr0.680 |
| EPS Surprise | 11.48% |
| Revenue estimate | 2.299B |
| Revenue actual | 2.177B |
| Revenue Surprise | -5.31% |
| Release date | Jul 17, 2025 |
| EPS estimate | kr0.580 |
| EPS actual | kr0.407 |
| EPS Surprise | -29.83% |
| Revenue estimate | 2.121B |
| Revenue actual | 2.078B |
| Revenue Surprise | -2.03% |
| Release date | May 07, 2025 |
| EPS estimate | kr0.440 |
| EPS actual | kr0.450 |
| EPS Surprise | 2.27% |
| Revenue estimate | 2.099B |
| Revenue actual | 2.039B |
| Revenue Surprise | -2.86% |
| Release date | Jan 29, 2025 |
| EPS estimate | kr0.510 |
| EPS actual | kr0.630 |
| EPS Surprise | 23.53% |
| Revenue estimate | 2.291B |
| Revenue actual | 2.285B |
| Revenue Surprise | -0.262% |
Last 4 Quarters for Cloetta AB (publ)
Below you can see how CLA-B.ST performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jan 29, 2025 |
| Price on release | kr27.44 |
| EPS estimate | kr0.510 |
| EPS actual | kr0.630 |
| EPS surprise | 23.53% |
| Date | Price |
|---|---|
| Jan 23, 2025 | kr24.58 |
| Jan 24, 2025 | kr24.24 |
| Jan 27, 2025 | kr24.38 |
| Jan 28, 2025 | kr24.60 |
| Jan 29, 2025 | kr27.44 |
| Jan 30, 2025 | kr28.20 |
| Jan 31, 2025 | kr28.30 |
| Feb 03, 2025 | kr28.38 |
| Feb 04, 2025 | kr27.86 |
| 4 days before | 11.64% |
| 4 days after | 1.53% |
| On release day | 2.77% |
| Change in period | 13.34% |
| Release date | May 07, 2025 |
| Price on release | kr31.48 |
| EPS estimate | kr0.440 |
| EPS actual | kr0.450 |
| EPS surprise | 2.27% |
| Date | Price |
|---|---|
| Apr 30, 2025 | kr28.10 |
| May 02, 2025 | kr28.58 |
| May 05, 2025 | kr28.76 |
| May 06, 2025 | kr28.52 |
| May 07, 2025 | kr31.48 |
| May 08, 2025 | kr32.44 |
| May 09, 2025 | kr32.42 |
| May 12, 2025 | kr32.10 |
| May 13, 2025 | kr32.14 |
| 4 days before | 12.03% |
| 4 days after | 2.10% |
| On release day | 3.05% |
| Change in period | 14.38% |
| Release date | Jul 17, 2025 |
| Price on release | kr32.98 |
| EPS estimate | kr0.580 |
| EPS actual | kr0.407 |
| EPS surprise | -29.83% |
| Date | Price |
|---|---|
| Jul 11, 2025 | kr33.36 |
| Jul 14, 2025 | kr33.32 |
| Jul 15, 2025 | kr32.96 |
| Jul 16, 2025 | kr33.70 |
| Jul 17, 2025 | kr32.98 |
| Jul 18, 2025 | kr32.80 |
| Jul 21, 2025 | kr33.16 |
| Jul 22, 2025 | kr32.12 |
| Jul 23, 2025 | kr31.94 |
| 4 days before | -1.14% |
| 4 days after | -3.15% |
| On release day | -0.546% |
| Change in period | -4.26% |
| Release date | Nov 05, 2025 |
| Price on release | kr34.62 |
| EPS estimate | kr0.610 |
| EPS actual | kr0.680 |
| EPS surprise | 11.48% |
| Date | Price |
|---|---|
| Oct 30, 2025 | kr35.66 |
| Oct 31, 2025 | kr35.40 |
| Nov 03, 2025 | kr35.32 |
| Nov 04, 2025 | kr35.38 |
| Nov 05, 2025 | kr34.62 |
| Nov 06, 2025 | kr34.18 |
| Nov 07, 2025 | kr34.18 |
| Nov 10, 2025 | kr34.20 |
| Nov 11, 2025 | kr34.46 |
| 4 days before | -2.92% |
| 4 days after | -0.462% |
| On release day | -1.27% |
| Change in period | -3.37% |
Cloetta AB (publ) Earnings Call Transcript Summary of Q3 2025
Key investor takeaways from Cloetta Q3: 1) Profitability momentum — Q3 adjusted EBIT margin reached 11.9% (rolling 12-month margin 11.4%), marking a sustained uplift and moving the company toward its midterm target of at least 12% by 2027. 2) Stable, profitable growth — Q3 organic sales growth was 1.3%, year-to-date organic growth 2.2%, with particularly strong performance in the Nordic region and double-digit growth in North America. Reported Q3 net sales were SEK 2.177 billion. 3) Strong cash generation and balance sheet — Q3 free cash flow of SEK 339 million; year-to-date free cash flow exceeded SEK 0.5 billion for the first time; net debt reduced to SEK 1.4 billion and net debt/EBITDA at 1.1 (below the new target of <1.5). The company repaid SEK 800 million of loans and has about SEK 2.5 billion in cash + unused facilities. 4) Strategic focus — priority on 10 Superbrands in five core markets (Sweden, Denmark, Norway, Finland, Netherlands), expansion in three high-potential markets (UK, Germany, North America), stepped-up marketing & innovation, and openness to M&A only as an accelerator (not required to meet targets). 5) Product innovation — highlighted launches: Malaco Fruit Drops (vegan, no artificial colours/flavours), Chewy Soft Bites (multi-market), and a successful limited Läkerol hot pepper pastille launch that brought >40% new category buyers. 6) Updated financial framework — long-term organic growth target raised to 3–4% (from 1–4% previously stated), long-term adjusted EBIT target remains 14% with an interim goal of at least 12% by 2027, net debt target below 1.5 (may be exceeded temporarily for compelling M&A), and dividend policy changed to above 50% of profit after tax. 7) Market/commodity context — cocoa costs have fallen from peaks (helpful for chocolate demand recovery) but timing of cost pass-through and inventory lags means benefits are gradual; Cloetta emphasizes “fair pricing” (price up when costs rise, roll back responsibly when costs fall). Overall conclusion: Cloetta reports a clear and measurable improvement in profitability and cash generation, with focused strategic initiatives and disciplined capital allocation aimed at returning margins to historic levels while supporting brand investment and selective growth.
Sign In
Buy CLA-B